# Comparison Between Intrathecal Magnesium Sulphate & Dexmedetomidine in DHS

> **NCT07326397** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 92 (estimated)

## Conditions studied

- Effects of Dexmedetomidine & Magnesium Sulphate on Patients Undergoing DHS

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Magnesium Sulphate

## Key facts

- **NCT ID:** NCT07326397
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-11-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07326397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07326397, "Comparison Between Intrathecal Magnesium Sulphate & Dexmedetomidine in DHS". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07326397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*